FDA won’t al­low In­vivyd’s Pem­gar­da to treat Covid; An­tibi­ot­ic biotech launch­es

Plus, news about BioCryst, AN2 Ther­a­peu­tics, OS Ther­a­pies and Eye­n­ovia:

FDA is not ex­pand­ing In­vivyd’s Covid-19 EUA: The reg­u­la­tors de­clined to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.